Stocklytics Platform
Asset logo for symbol RPRX
Royalty Pharma PLC
RPRX63
$28.00arrow_drop_up1.13%$0.31
Asset logo for symbol RPRX
RPRX63

$28.00

arrow_drop_up1.13%

AI Deep-Learning Forecast (RPRX)

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

Royalty Pharma PLC (RPRX) Stocklytics Forecast

Royalty Pharma PLC (RPRX) is a leading healthcare investment company focused on acquiring and managing royalty interests in pharmaceutical and biotechnology products. The company has a proven track record of delivering strong returns to its investors, and the future looks promising for RPRX. With the increasing demand for innovative and life-saving drugs, Royalty Pharma is well-positioned to capitalize on this growing market. The company's diverse portfolio of royalty interests provides a stable and predictable income stream, making it an attractive investment option for both long-term and short-term investors.

The stock price of Royalty Pharma (RPRX) is expected to experience growth in the coming years. Analysts predict that the company's earnings will continue to increase, driven by strong sales of its royalty assets and a robust pipeline of potential new investments. The favorable regulatory environment and the growing trend of mergers and acquisitions in the pharmaceutical industry further support the positive outlook for RPRX. In addition, Royalty Pharma's partnerships with leading pharmaceutical companies provide it with access to a wide range of promising royalty assets, ensuring a steady flow of future revenue.

add Royalty Pharma PLC to watchlist

Keep an eye on Royalty Pharma PLC

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help
What is the analyst price prediction for Royalty Pharma PLC (RPRX) stock?

Analysts have set a target price of $51.59 for Royalty Pharma PLC (RPRX), based on forecasts from 17 analysts. The predicted price range extends from a high of $60 to a low of $42. This represents a potential increase of up to 114.25% and a decrease of 49.97% from the current price of $28. These forecasts are as of 2020 Jul 13.

help
What are the analyst ratings for Royalty Pharma PLC (RPRX) stock?

Currently, there are no analyst ratings available for Royalty Pharma PLC (RPRX), possibly due to insufficient coverage or recent updates.

help
What is the AI price prediction for Royalty Pharma PLC (RPRX) stock?

At present, there is no AI or machine-learning-based price prediction available for Royalty Pharma PLC (RPRX) stock. The lack of a forecast could stem from various factors, such as inadequate data or the necessity for model recalibration.

email

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level